Abbott Laboratories Aktie

Abbott Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850103 / ISIN: US0028241000

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
16.04.2025 14:11:41

Abbott Laboratories Q1 Profit Increases, Beats Estimates

(RTTNews) - Abbott Laboratories (ABT) announced earnings for its first quarter that increased from last year and beat the Street estimates.

The company's earnings totaled $1.325 billion, or $0.76 per share. This compares with $1.225 billion, or $0.70 per share, last year.

Excluding items, Abbott Laboratories reported adjusted earnings of $1.919 billion or $1.09 per share for the period.

Analysts on average had expected the company to earn $1.07 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 4.0% to $10.358 billion from $9.964 billion last year.

Abbott Laboratories earnings at a glance (GAAP) :

-Earnings: $1.325 Bln. vs. $1.225 Bln. last year. -EPS: $0.76 vs. $0.70 last year. -Revenue: $10.358 Bln vs. $9.964 Bln last year.

-Guidance: Next quarter EPS guidance: $1.23 - $1.27 Full year EPS guidance: $5.05 - $5.25

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 115,50 -0,41% Abbott Laboratories